Cargando…
Reversal of cognitive decline: A novel therapeutic program
This report describes a novel, comprehensive, and personalized therapeutic program that is based on the underlying pathogenesis of Alzheimer's disease, and which involves multiple modalities designed to achieve metabolic enhancement for neurodegeneration (MEND). The first 10 patients who have u...
Autor principal: | Bredesen, Dale E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221920/ https://www.ncbi.nlm.nih.gov/pubmed/25324467 |
Ejemplares similares
-
Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016) -
ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline
por: Rao, Rammohan V, et al.
Publicado: (2021) -
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023) -
Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014) -
Chemically induced reprogramming to reverse cellular aging
por: Yang, Jae-Hyun, et al.
Publicado: (2023)